Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Key facts
Counted staff
5
self-reported 2–10 band
Founded
2009
17 years
Legal entities
None matched
Office countries
1
1 address
Funding rounds
None on record
Company type
Nonprofit
self-reported
Description
Angelman syndrome (AS) is a rare neurogenetic disorder that affects approximately one in 15,000 people – about 500,000 individuals worldwide. Symptoms include, but are not limited to: delayed developmental milestones; gross and fine motor impairment; difficulty with feeding and swallowing; issues; loss of functional speech and epilepsy.
FAST has a vision of a world where lives are no longer limited by a diagnosis of Angelman syndrome.
The mission of the Foundation for Angelman Syndrome Therapeutics Australia is to improve the quality of life for individuals with Angelman syndrome through timely diagnosis, access to best practices in care and treatments, and advancing research for a cure.
Locations
Country footprint
Show as table · Offices in 1 country
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
Addresses
- AUCairns, QueenslandPrimary
Grid intelligence Members
Signals & hiring
Hiring, headcount and registry-change signals, streamed to members.
Latest signal
Hiring activity
Headcount trend
Financials
Registry-filed capital and financial indicators, standardised by TheGrid.
Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
People & contacts
2 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Counts only. No names are stored here, and none are served.
FAQ
How many people work at FAST Australia - Foundation for Angelman Syndrome Therapeutics?
The record holds 5 counted staff profiles at January 2026, inside the self-reported 2–10 band.
Where does FAST Australia - Foundation for Angelman Syndrome Therapeutics have offices?
One address on record, Australia only. Primary: Cairns, Queensland.
Has FAST Australia - Foundation for Angelman Syndrome Therapeutics raised funding?
None linked to this brand.
Which companies are listed alongside this brand?
1 profile lists FAST Australia - Foundation for Angelman Syndrome Therapeutics as a peer — 44th percentile in Research Services. It lists ten peers of its own. Prader-Willi Research Foundation of Australia lists it back.